Food and drug regulation in an era of globalized markets

Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing ph...

Full description

Saved in:
Bibliographic Details
Main Author: Halabi, Sam F.
Format: eBook Book
Language:English
Published: Amsterdam Academic Press 2015
Elsevier Science & Technology
Edition:1
Subjects:
ISBN:9780128023112, 0128023112
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India.
AbstractList Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India.
Author Halabi, Sam F.
Author_xml – sequence: 1
  fullname: Halabi, Sam F.
BackLink https://cir.nii.ac.jp/crid/1130000798296098432$$DView record in CiNii
BookMark eNpNTz1PwzAUNOJDlNKZ1QMSU-A9f8TPI0QtIFViQayVE9tVaLAhSRd-PUFlYLnTnU6nuwt2knIKjF0h3CJgeVcJQFVAAcKiLOwRW1hDgIJAaA36-J-WiOKMzSzaEpEMnbPFMLwDABpdAugZo1XOnrvkue_3W96H7b5zY5sTb9Nk89A7niPfdrl2XfsdPP9w_S6MwyU7ja4bwuKP5-xttXytnor1y-Nzdb8unCJNqkA0nmztjYhBm4BUgyYtQwPexGlSUCo2hFKXwtW1dmVDOkpyoERD0ZZyzm4OxZ99_tqHYdyEOuddE9LYu26zfKgETocNTcnrQzK17aZpfxFRTm_BWBK2BEtKCvkDGc5YvQ
ContentType eBook
Book
DBID RYH
DEWEY 344.04232
DOI 10.1016/C2014-0-02913-9
DatabaseName CiNii Complete
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Law
EISBN 9780128025505
0128025506
Edition 1
ExternalDocumentID EBC2197878
BB22789984
GroupedDBID 20A
38.
AAAAS
AABBV
AAFKH
AAFLS
AAIVD
AAJFB
AAKGN
AALRI
AANYM
AAORS
AAXUO
AAYFD
AAZGR
AAZNM
ABARN
ABGWT
ABIWA
ABLHP
ABMAC
ABQNV
ABQPQ
ABQQC
ABRSK
ACLCD
ACLGV
ACXMD
ADCEY
ADVEM
AECLD
AERYV
AFOST
AFSFD
AGAMA
AHMUE
AHWGJ
AJFER
AJMPQ
ALMA_UNASSIGNED_HOLDINGS
AMINO
APVFW
ASVZH
ATDNW
AZZ
BBABE
BIOBC
BIQZX
BNZFE
CDLGT
CZZ
DJNCR
E2F
EEHNK
HGY
JJU
L7C
LLQQT
LNXRZ
MYL
O7H
PQQKQ
PXDKH
RYH
SDK
SHL
SRW
UE6
ID FETCH-LOGICAL-a48584-117d89bd72fe57e18b05853ec0d7f878e44fc813562abb5a6c85f38a042c8f963
ISBN 9780128023112
0128023112
IngestDate Wed Nov 26 07:40:21 EST 2025
Thu Jun 26 22:37:44 EDT 2025
IsPeerReviewed false
IsScholarly false
LCCallNum_Ident K3636.F663 2015
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a48584-117d89bd72fe57e18b05853ec0d7f878e44fc813562abb5a6c85f38a042c8f963
Notes Includes bibliographical references and index
OCLC 919611878
PQID EBC2197878
PageCount 258
ParticipantIDs proquest_ebookcentral_EBC2197878
nii_cinii_1130000798296098432
PublicationCentury 2000
PublicationDate c2015
2015
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – year: 2015
  text: c2015
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Chantilly
PublicationYear 2015
Publisher Academic Press
Elsevier Science & Technology
Publisher_xml – name: Academic Press
– name: Elsevier Science & Technology
SSID ssj0001756005
ssib030802718
Score 1.9603155
Snippet Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade...
SourceID proquest
nii
SourceType Publisher
SubjectTerms Drugs
Drugs -- Law and legislation
Food law and legislation
Law and legislation
TableOfContents Return Mobility to Cities Through Innovative Infrastructure Investments -- The Future -- Conclusion -- Chapter 10: Divide and Confound: The Relationship Between Transparency, Public Health, and Regulatory Authority in the Nat ... -- Chapter 11: Global Administrative Law and the FDA's Collaborative Agreements with International Regulatory Partners -- The Food Safety Modernization Act and the Prioritization of International Regulatory Partnerships -- International Agreements: Typologies and Objectives -- Confidentiality Agreements -- Statements of Cooperation or Intent -- Exchanges of Letters -- Memoranda of Understanding -- Systems Recognition -- Agreements Within Broader Bilateral Cooperative Partnerships -- Agreements or Quasi-Treaties -- Conclusion -- Chapter 12: Effective Regulation of Food Additives -- Pew's Approach -- Pew's Findings -- Conflicts of Interest -- Lack of Information -- Outdated Science -- Missing Safety Deadlines -- Pew's Recommendations -- Close the GRAS Loophole -- Modernize the FDA's Food Additive Science -- Ensure That Existing Chemical Additives Are Safe -- Establish a Fee-Based Funding Program -- Chapter 13: Protecting Consumers through New Regulations, Inspection, and Verification under the U.S. Food Safety Moderniz ... -- Introduction -- Preventive Controls for Human Food -- Produce Safety -- Foreign Supplier Verification Program -- Third-Party Certification Program -- Enforcement and Funding of the FSMA -- Chapter 14: The Evolving Role of the Codex Alimentarius Commission in Securing Consumer Protection in Globalized Food Markets -- The Infrastructure of the Codex Alimentarius Commission -- A Brief History -- Organizational Structure -- Leadership -- Codex Executive Committee -- Codex Secretariat -- Codex Subsidiary Bodies -- Codex Session Procedures -- Codex in Practice: A Brief Look at Some Global Challenges
Internal Design -- Outside Influences -- Other International Institutions -- Industry -- Codex in the Twenty-First Century -- Chapter 15: The Emergence and Influence of Transnational Private Regulation of Food Safety -- Introduction -- The Development of TPR in Global Food Safety Governance -- Global Sourcing, Local Consumption -- Globalized Food Supply Chains and Outbreaks -- Reputational Risks to the Food Industry -- Public Distrust of Governmental Regulatory Reforms and a Shift of Responsibility -- Strengths of TPR of Food Safety -- Technical Expertise -- Effective and Efficient Cross-Border Supply Chain Control -- Regulatory Adaptability -- Cooperative and Proactive Nature -- Weaknesses of TPR of Food Safety -- Agency-Client Relationship, Checklist Governance, and Second-Level Information Asymmetry -- Legitimacy and Accountability Concerns -- Distributional Impact on Small Farmers and Developing Countries -- Conclusion -- Interactions Between TPR and National Authorities -- Interactions Between TPR and International Organizations -- Governance Through Constructive Interactions -- Index
Front Cover -- Food and Drug Regulation in an Era of Globalized Markets -- Copyright -- Contents -- Contributors -- Foreword -- Introduction -- The Rise of a Global System for Food and Pharmaceuticals -- Conceptualizing Food and Drug Regulation in Globalized Markets: Interdisciplinarity and Governance -- The Plan of This Book -- Acknowledgments -- Acknowledgments -- Part I: Governance, Regulation, and Vulnerabilities of Globalized Pharmaceutical Supply Chains -- Chapter 1: Addressing Emerging Challenges in the Pharmaceutical Product Development Ecosystem -- Introduction -- Approaches to Reduce Drug Development Costs and Speed Innovation -- Clinical Trials: Reducing Costs, Speeding Development: New Approaches to Patient Recruitment, Study Design, and Settings -- Adaptive Design -- Clinical Trials: Globalization -- New Approaches to Endpoints: Biomarkers, Patient Reporting, and Remote Monitoring -- The Supply Chain: How Are We Vulnerable and What Are Potential Solutions? -- Big (More and More) Data: Swim or Drown? -- Conclusion -- Chapter 2: FDA's Global Investigation and Enforcement Authority, Partnerships, and Priorities -- Introduction -- Adulteration, Misbranding, and GMPs -- FDA Establishment Inspections -- FDA Enforcement Instruments Related to Manufacturing -- Foreign Inspections -- Conclusion -- Chapter 3: The European Medicines Agency and the Regulation of Medicines in the European Union -- Introduction -- Approval of Drugs in Europe -- The European Medicines Agency: Its Role and Activities -- Ema Support In The Early Stages Of Drug Development -- The Centralized Procedure AT WORK -- Assessment overview -- Single Assessment Report -- Patients in the Scientific Review Process -- Transparency and the Centralized Procedure -- EMA-FDA Cooperation -- Cooperation in the Product Life Cycle -- Cooperation in Inspections
Benefits of International Cooperation -- References -- Chapter 4: Human Clinical Trials and Drug Approvals: Transnational Issues -- Introduction -- Taking Clinical Trials Abroad -- Overlapping Legal and Regulatory Requirements -- Legal Landscape in the United States: FDA Oversight of Clinical Trials -- Legal Landscape in the EU: EU Clinical Trial Directives and Regulation -- International Legal Landscape: International Clinical Practice Standards -- National and Local Legal Standards -- Practical Considerations in Conducting Global Trials -- Deciding Whether to Conduct the Foreign Clinical Trial Under an IND -- Identifying Experienced Contractors and Contract Research Organizations -- Managing Idiosyncratic Foreign Sites and Investigators -- Conclusion -- Further Reading -- Chapter 5: Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains: Toward Actionable Solutions -- Globalization's Influence on the Pharmaceutical Supply Chain -- The Effects of the Global Market for Falsified and Substandard Medicines -- Barriers to Global Solutions for the Problem of Falsified and Substandard Medicines -- Combating Falsified and Substandard Medicines through Regulatory Cooperation -- Conclusion -- Chapter 6: Regulatory Capacity in Low- and Middle-Income Countries: Lessons from the H1N1 Influenza Pandemic -- Introduction -- Pandemic Influenza: Background and Basics of Public Health System Response -- Pandemic H1N1 and the Global Response -- Regulatory Barriers and Legal Barriers IMPACT Participation in the Global Response -- Lack of Regulatory Capacity Stymies Efforts to Distribute Pandemic Vaccine after Legal Agreements Are Concluded -- The Role of Investment in Regulatory Capacity and the Effectiveness of the WHO Pandemic Influenza Preparedness Framework -- Conclusion
Chapter 7: Prime Minister Narendra Modi's Government and Its Impact on the Indian Pharmaceutical Sector -- Introduction -- Ministry of Health &amp -- Family Welfare -- Ministry of Chemicals &amp -- Fertilizers -- Ministry of Science &amp -- Technology -- Ministry of Commerce &amp -- Industry -- Ministry of Finance -- Emerging Patterns in the Pharmaceutical Regulatory Environment under the Modi Government -- Chapter 8: Regulatory Challenges for Medical Devices and Drugs Under the China Food and Drug Administration -- China's Political and Regulatory Goals: The Context for Drug and Device Regulation -- Drugs -- Patented and Generic Drugs -- Registration -- Clinical Trials -- Manufacture and Sale of Drugs -- Drugs That Have Been Licensed/Approved in Other Jurisdictions -- Advertising -- Anticorruption Compliance -- Devices -- Importing and Registering Medical Devices -- Clinical Trials -- Advertising Medical Devices -- New Device Regulations-State Council Order No. 650 -- Registration and Filing Requirements -- Clinical Trials -- Increased Legal Penalties and Liabilities -- Practical Tips -- Acknowledgments -- Part II: Designing Optimal Regulatory Structures to Address Diversifying and Globalizing Sources of Food and Additives -- Chapter 9: The Balance Between Regulation and Private-Sector Initiative in Securing Healthy and Sustainable Food -- Introduction -- Historical Context -- Challenge: Supporting Healthy Diets and Environmental Sustainability -- Narrow Scope of Nutrition Policy -- Lack of Investment in Broad-Based Solutions -- Relationship with the Private Sector -- Limited Capacity to Enforce Laws -- The Way Forward -- Foster New Models of Collaboration -- Embrace the Shift Toward Libertarian Paternalism -- Enhance the Role of Government -- Lever Core Capabilities of Companies -- Build on 40 Years of Partnerships Between Unlikely Partners
Title Food and drug regulation in an era of globalized markets
URI https://cir.nii.ac.jp/crid/1130000798296098432
https://ebookcentral.proquest.com/lib/[SITE_ID]/detail.action?docID=2197878
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV07T8MwELZoYWDjKQoUeWCrDHXi1Oe1VSuGghgQYqucxEYZSFHaQsWv55xnVQbEwGIlHmzlO-devgch18I32ho8vCjdPCYMcKa0ASaUu3UTUsR5KaXnqXx4gJcX9Vh2x1vk7QRkmsJ6rd7_ldQ4h8R2qbN_IHe9KE7gMxIdRyQ7jlsacf1addmc53VXe3G2eu1lRZP5MpQR_2KTaacZFhVAki9UNN_yjOdFw4TwRCSFm_itN7nZdAjwYMsh0MTVb8RwFOaiE0au3lsRuPyDeRZ2_AjXFKzP-p7iPlONnKij94bDPH9WgWiRFporbbKLMnR83_i2pNOjgryCUbVjWeyofq_KLPHB7daOKOXTJPkhG3OB_3RA2i4J5JDsmPSItKb685iAw5civtThSxt8aZLiNEV86dzSBl9a4ntCnifjp9EdK_tOMC0AFTLGuYxBhbH0rAmk4RD20aryTdSPpQUJRggbAfdRd9RhGOhBBIH1QSMDjMAiSzsl7XSemjNCwcYGjMtQdg42HoKOLJgoRMXJ-oEvO6SLHzuLEjdyd7eISpsCzxUCBOF7HUIrGGb59XkZszsbD0cobJDdwvkvS1yQ_eaYXJL2MluZLtmLPpbJIrsqafcNUNwS0A
linkProvider ProQuest Ebooks
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.title=Food+and+drug+regulation+in+an+era+of+globalized+markets&rft.au=Halabi%2C+Sam+F.&rft.date=2015-01-01&rft.pub=Academic+Press&rft.isbn=9780128023112&rft_id=info:doi/10.1016%2FC2014-0-02913-9&rft.externalDocID=BB22789984
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=9780128023112/lc.gif&client=summon&freeimage=true
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=9780128023112/mc.gif&client=summon&freeimage=true
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=9780128023112/sc.gif&client=summon&freeimage=true